Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAND PHARMA

5.960
+0.000
Volume:7.40M
Turnover:44.23M
Market Cap:21.16B
PE:8.46
High:6.110
Open:5.980
Low:5.890
Close:5.960
Loading ...

Grand Pharmaceutical's Hepatocellular Carcinoma Diagnosis Drug Exhibits Safety, Efficacy in Trial

MT Newswires Live
·
22 Apr

Grand Pharmaceutical Gets Registration Certificate for Nasal Spray in China

MT Newswires Live
·
22 Apr

BRIEF-Grand Pharmaceutical's Fluticasone Propionate Nasal Spray Approved For Commercialization in China

Reuters
·
22 Apr

Grand Pharmaceutical - Generic Fluticasone Propionate Nasal Spray in China Approved for Commercialization by Nmpa

THOMSON REUTERS
·
22 Apr

There's A Lot To Like About Grand Pharmaceutical Group's (HKG:512) Upcoming HK$0.26 Dividend

Simply Wall St.
·
09 Apr

Grand Pharma Group Doses First Patient in Tumor Drug Clinical Trial

MT Newswires Live
·
20 Mar

Grand Pharmaceutical Group Limited's (HKG:512) market cap increased by HK$3.5b, insiders receive a 49% cut

Simply Wall St.
·
14 Mar

Grand Pharmaceutical Group Divests 45% of Telix Pharmaceuticals Shares

MT Newswires Live
·
04 Mar

BRIEF-Grand Pharmaceutical Provides Update On Strategic Investment In Telix

Reuters
·
28 Feb

Grand Pharmaceutical Group Ltd - Update on Strategic Investment in Telix

THOMSON REUTERS
·
28 Feb

Little Excitement Around Grand Pharmaceutical Group Limited's (HKG:512) Earnings

Simply Wall St.
·
24 Feb

Grand Pharmaceutical - Proposed Partial Exercise of Right to Acquire Remaining Equity Interest in Nanjing Kainite Medical Technology

THOMSON REUTERS
·
21 Feb

Grand Pharmaceutical's Liver Cancer Treatment Study Enrols First Patient

MT Newswires Live
·
03 Jan

Grand Pharmaceutical Group's Ophthalmic Product Gets Drug Approval in China

MT Newswires Live
·
17 Dec 2024

BRIEF-Grand Pharmaceutical Says NDA For Group Treated For Demodex Blepharitis Accepted By Nmpa

Reuters
·
16 Dec 2024

Grand Pharmaceutical - Nda for Group Treated for Demodex Blepharitis Has Been Accepted by Nmpa China

THOMSON REUTERS
·
16 Dec 2024

Grand Pharmaceutical Registers Intravascular Imaging Device in China

MT Newswires Live
·
12 Dec 2024

BRIEF-Grand Pharmaceutical Says Novasync Approved By NMPA For Commercialization In China

Reuters
·
12 Dec 2024

Grand Pharmaceutical - Global Innovative Intravascular Dual-Mode Imaging System Novasync Approved by Nmpa for Commercialization in China

THOMSON REUTERS
·
12 Dec 2024

BRIEF-Grand Pharmaceutical Obtained Exclusive Development & Commercialization Rights Of Product

Reuters
·
11 Dec 2024